Recent News

• 03.10.2025 - Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
• 03.03.2025 - Immunocore to present at upcoming investor conferences
• 02.26.2025 - Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
• 02.19.2025 - Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
• 01.10.2025 - Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

• 03.10.2025 - 8-K Current report
• 03.10.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 3 Initial statement of beneficial ownership of securities
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2025 - 8-K Current report
• 02.26.2025 - EX-99.1 EX-99.1
• 02.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities